down arrow

Alembic Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
840.00
1.5 (0.18%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 87.77 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Jubilant Pharmo
Cipla
Caplin Point Lab
Sun Pharma.Inds.
Sanofi India
Torrent Pharma
Alembic Pharma
Neuland Labs.
Mankind Pharma
Sai Life
Why is Alembic Pharmaceuticals Ltd. ?
1
Poor long term growth as Operating profit has grown by an annual rate -5.07% of over the last 5 years
2
Negative results in Dec 24
  • INTEREST(HY) At Rs 41.07 cr has Grown at 70.27 %
  • PAT(Q) At Rs 138.42 cr has Fallen at -23.3 %
  • OPERATING PROFIT TO INTEREST (Q) Lowest at 11.69 times
3
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 07-Apr-25
  • The stocks Bollinger Band and KST technical factors are also Bearish
4
Below par performance in long term as well as near term
  • Along with generating -14.59% returns in the last 1 year, the stock has also underperformed BSE 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Alembic Pharma for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Alembic Pharma
-15.39%
-0.37
39.46%
SENSEX
0.45%
0.02
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
8.21%
EBIT Growth (5y)
-5.07%
EBIT to Interest (avg)
30.79
Debt to EBITDA (avg)
0.85
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.00
Tax Ratio
13.54%
Dividend Payout Ratio
35.11%
Pledged Shares
0
Institutional Holding
20.23%
ROCE (avg)
15.20%
ROE (avg)
14.23%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
28
Industry P/E
33
Price to Book Value
3.37
EV to EBIT
24.28
EV to EBITDA
17.48
EV to Capital Employed
2.99
EV to Sales
2.71
PEG Ratio
27.76
Dividend Yield
1.31%
ROCE (Latest)
12.43%
ROE (Latest)
13.01%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
NET SALES(Q)

Highest at Rs 1,692.74 cr

-15What is not working for the Company
INTEREST(HY)

At Rs 41.07 cr has Grown at 70.27 %

PAT(Q)

At Rs 138.42 cr has Fallen at -23.3 %

OPERATING PROFIT TO INTEREST (Q)

Lowest at 11.69 times

DEBT-EQUITY RATIO(HY)

Highest at 0.22 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.01 times

PBT LESS OI(Q)

At Rs 168.28 cr has Fallen at -7.39 %

Loading Valuation Snapshot...
Here's what is working for Alembic Pharma
Net Sales - Quarterly
Highest at Rs 1,692.74 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Alembic Pharma
Profit After Tax (PAT) - Quarterly
At Rs 138.42 cr has Fallen at -23.3 %
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Operating Profit to Interest - Quarterly
Lowest at 11.69 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest - Quarterly
Highest at Rs 22.26 cr
in the last five quarters and Increased by 18.34 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 168.28 cr has Fallen at -7.39 %
Year on Year (YoY)
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Debt-Equity Ratio - Half Yearly
Highest at 0.22 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio- Half Yearly
Lowest at 5.01 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."